The Dr. Agarwal’s Health Care IPO is generating significant buzz in the market, with investors closely monitoring its Grey Market Premium (GMP) and performance trends. This blog provides live updates on the IPO’s GMP, Kostak rates, and Subject to Sauda rates, alongside essential IPO details.
Dr. Agarwal’s Health Care IPO GMP Live Updates
The Grey Market Premium (GMP) is an indicator of investor demand before the IPO listing. Below are the GMP trends:
Date | IPO GMP | GMP Trend | Subject to Sauda |
---|---|---|---|
30 January | ₹10 | GMP Down | ₹300 |
29 January | ₹10 | GMP Down | ₹300 |
28 January | ₹10 | GMP Down | ₹300 |
27 January | ₹40 | GMP Down | ₹1,000 |
25 January | ₹55 | GMP Up | ₹2,000 |
24 January | ₹- | – | ₹- |
Note: The GMP value reflects the market sentiment but does not guarantee IPO listing gains.
Dr. Agarwal’s Health Care IPO Key Details
- IPO Open Date: January 29, 2025
- IPO Close Date: January 31, 2025
- Face Value: ₹1 per share
- Price Band: ₹382 – ₹402 per share
- Lot Size: 35 shares
- Total Issue Size: ₹3,027.26 Cr
- Fresh Issue: ₹300 Cr
- Offer for Sale: 6,78,42,284 shares (~₹2,727.26 Cr)
- Issue Type: Book Built Issue IPO
- Listing: BSE & NSE
- Retail Quota: 35%
- QIB Quota: 50%
- NII Quota: 15%
Dr. Agarwal’s Health Care IPO Timeline
Event | Date |
---|---|
IPO Open Date | January 29, 2025 |
IPO Close Date | January 31, 2025 |
Basis of Allotment | February 3, 2025 |
Refunds Initiated | February 4, 2025 |
Shares Credited | February 4, 2025 |
IPO Listing Date | February 5, 2025 |
About Dr. Agarwal’s Health Care
Established in 2010, Dr. Agarwal’s Health Care Limited has grown into a leading provider of eye care services. The company offers a diverse range of products and services, including:
- Primary Facilities: Optical sales, contact lenses, and accessories.
- Secondary Facilities: Cataract and reconstructive surgeries.
- Tertiary Facilities: Centers of Excellence (COEs) for advanced treatments.
As of March 31, 2024, the company operates:
- 3 COEs under tertiary facilities.
- 26 hubs with 139 spokes.
- A total of 180 facilities across India.
FAQs on Dr. Agarwal’s Health Care IPO GMP
What is Dr. Agarwal’s Health Care IPO GMP Today?
The GMP is ₹40 as of January 27, 2025.
What is Dr. Agarwal’s Health Care IPO Kostak Rate Today?
The Kostak rate is currently not available.
What is Dr. Agarwal’s Health Care IPO Subject to Sauda?
Subject to Sauda rate is ₹1,000.
What are the expected returns for Dr. Agarwal’s Health Care IPO?
The expected returns are approximately 10%.
Conclusion
The Dr. Agarwal’s Health Care IPO GMP reflects strong investor interest despite slight fluctuations. With its robust financials and extensive network in eye care services, the company is poised for a promising debut on the stock exchanges. Investors should monitor the GMP trends and make informed decisions based on their investment goals.
Disclaimer: GMP rates are indicative and may change. This blog does not endorse trading in the grey market. Always consult a financial advisor before investing.